雲南白藥(000538.SZ):國有股權管理公司與新華都實業集團並列公司第一大股東
格隆匯5月26日丨雲南白藥(000538.SZ)公佈,於2020年4月9日接到股東雲南省人民政府國有資產監督管理委員會(以下簡稱“雲南省國資委”)發來的《關於將所持雲南白藥股份劃轉註入雲南省國有股權運營管理有限公司的通知》(雲國資產權〔2020〕52號),雲南省國資委擬將其持有的本公司3.21160222億股股份(佔本公司股份總數的25.14%)無償劃轉給其下屬的獨資公司雲南省國有股權運營管理有限公司(以下簡稱“國有股權管理公司”)持有。
2020年5月26日,本公司收到國有股權管理公司轉發的由中國證券登記結算有限責任公司出具的《證券過户登記確認書》,確認上述國有股份無償劃轉的股份過户登記手續已辦理完畢,過户日期為2020年5月22日,股份性質為首發後限售股。本次無償劃轉完成後,國有股權管理公司持有本公司3.21160222億股股份(佔本公司股份總數的25.14%),與新華都實業集團股份有限公司及其一致行動人並列本公司的第一大股東,本公司無實際控制人情況不變。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.